Quantitative Sensory Testing (QST) in Drug-Naïve Patients with Parkinson’s Disease
Autor: | Ulrike Bingel, Katharina Schmidt, Carsten Buhmann, Tina Mainka, Wiebke Grashorn, Odette Fründt, Katarina Forkmann |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male 0301 basic medicine medicine.medical_specialty Parkinson's disease Sensory processing medicine.medical_treatment Medizin Sensory system Somatosensory system 03 medical and health sciences Cellular and Molecular Neuroscience 0302 clinical medicine Physical Stimulation Internal medicine medicine Humans Aged Aged 80 and over business.industry Dopaminergic Age Factors Chronic pain Parkinson Disease Middle Aged medicine.disease Drug-naïve 030104 developmental biology Case-Control Studies Sensory Thresholds Neuropathic pain Female Neurology (clinical) Chronic Pain business 030217 neurology & neurosurgery medicine.drug |
Zdroj: | Journal of Parkinson's Disease. 9:369-378 |
ISSN: | 1877-718X 1877-7171 |
DOI: | 10.3233/jpd-181513 |
Popis: | BACKGROUND Pain is highly prevalent in patients with Parkinson's disease (PD), but underlying pathophysiological mechanisms are largely unclear. Alterations in somatosensory processing might contribute to sensory abnormalities in PD. OBJECTIVE This study investigated sensory processing in PD patients. METHODS We used the standardized "Quantitative Sensory Testing" (QST) protocol (German Research Network on Neuropathic Pain) to investigate 13 somatosensory parameters in 19 PD patients naive to dopaminergic medication and 19 healthy controls matched for age, gender, and handedness. We tested for differences in sensory parameters between i) drug-naive PD patients and healthy controls, ii) patients' more and less affected body side, and iii) for an association of somatosensory parameters with disease-specific factors. RESULTS We did not observe any significant group differences in somatosensory parameters between PD patients and healthy subjects. In PD patients, QST mean z-scores did not differ between the predominantly and the less affected body side, PD patients with and without PD-specific chronic pain or between different PD subtypes. Age, but not PD disease severity, was associated with a greater loss of function in thermal and mechanical detection thresholds. CONCLUSIONS Somatosensory processing, as assessed with the well-established QST protocol, was normal in drug-naive PD patients. Thus, somatosensory abnormalities previously reported in medicated PD patients might rather be a result of dopaminergic medication, or may occur later in the course of the disease or with increasing age. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |